Texas Court Enforces Non-Compete After Rival Employer Promises to Cover Fallout

Why It Matters

The ruling signals that Texas courts will enforce non‑compete clauses despite a rival’s willingness to absorb costs, raising the compliance risk for healthcare HR teams when hiring former competitors. It underscores the need for clear contract language and diligent due‑diligence in talent moves.

Key Takeaways

• Liquidated damages clause is not a buyout without explicit language.
• Competitor’s promise to pay legal fees doesn’t void existing non‑compete.
• Texas courts enforce three‑year, 20‑mile restrictions on CRNAs.
• HR must verify non‑compete terms before hiring former competitors.

Pulse Analysis

Non‑compete agreements have become a staple in protecting proprietary talent, especially in high‑skill sectors like anesthesia services. Texas, long known for its business‑friendly stance, continues to uphold these clauses when they are reasonable in duration and geography. The Dubois v. Anesthesia Associates case illustrates how courts interpret liquidated‑damages provisions—not as automatic buyouts, but as supplemental remedies that coexist with injunctive relief. This distinction matters because it determines whether a departing professional can simply pay a fee to escape the covenant or must still honor the geographic restraint.

In this dispute, EmergencHealth attempted to sidestep the original non‑compete by offering to shoulder legal costs and damages for the four CRNAs. The appellate court rejected that strategy, emphasizing that contractual language, not employer goodwill, governs enforceability. For HR leaders, the lesson is clear: any assumption that a new employer can nullify an existing covenant through financial promises is legally precarious. Thorough contract reviews and explicit buyout clauses are essential to avoid costly litigation and operational disruptions, especially when staffing shortages already strain hospital schedules.

The broader impact on the healthcare labor market could be significant. As hospitals grapple with a national shortage of qualified CRNAs, the risk of losing talent to competitors is heightened. Organizations must balance competitive compensation packages with robust legal safeguards, ensuring that non‑compete terms are narrowly tailored and clearly communicated. Failure to do so may not only trigger injunctions but also erode goodwill and increase turnover costs, ultimately affecting patient care delivery and financial performance.